ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Ovarian Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma
Endometrial Cancer

Prostate Cancer trials near Salt Lake City, UT, USA:

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs (ANDROMEDA)

ANDROMEDA is a first-in-human, Phase I/II, open-label, multicenter study of AZD9750 in participants with metastatic prostate cancer...

Enrolling
Prostate Cancer
Drug: AZD5305
Drug: AZD9750

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Salt Lake City, Utah, United States and 17 other locations

The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer...

Enrolling
Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Prostate Cancer Patients Treated by Radiotherapy
Drug: 64Cu-SAR-bisPSMA

Phase 3

Clarity Pharmaceuticals

Salt Lake City, Utah, United States and 27 other locations

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...

Active, not recruiting
Prostate Cancer
Drug: Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Phase 4

Lantheus Medical Imaging
Lantheus Medical Imaging

Salt Lake City, Utah, United States and 13 other locations

The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...

Enrolling
Prostate Cancer
Drug: AMG 509
Drug: Abiraterone

Phase 1

Amgen
Amgen

Murray, Utah, United States and 57 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Placebo
Drug: Prednisone

Phase 2, Phase 3

Lilly
Lilly

Salt Lake City, Utah, United States and 113 other locations

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Enrolling
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

Salt Lake City, Utah, United States and 328 other locations

the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Drug: Darolutamide (Nubeqa®) 300 mg tablets
Drug: ORIC-944

Phase 1

Oric Pharmaceuticals

Salt Lake City, Utah, United States and 26 other locations

Status recently updated

second-line androgen receptor (AR) directed therapy with enzalutamide or docetaxel (chemotherapy) for treating metastatic castration-resistant prostate...

Enrolling
Active, not recruiting
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Drug: PF-06821497
Drug: Enzalutamide

Phase 3

Pfizer
Pfizer

Salt Lake City, Utah, United States and 230 other locations

Locations recently updated

compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Docetaxel
Drug: Abiraterone

Phase 3

Celgene
Celgene

Murray, Utah, United States and 282 other locations

This is an open-label, phase II umbrella trial assessing the anti-tumor activity of enfortumab alone and in combination with other anti-cancer...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: Enfortumab vedotin

Phase 2

Utah System of Higher Education (USHE)
Utah System of Higher Education (USHE)

Salt Lake City, Utah, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems